End-of-day quote
Shanghai S.E.
23:00:00 04/07/2024 BST
|
5-day change
|
1st Jan Change
|
30.43
CNY
|
+0.43%
|
|
-2.59%
|
-23.23%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,000
|
23,347
|
16,679
|
12,804
|
-
|
-
|
Enterprise Value (EV)
1 |
26,000
|
23,347
|
16,679
|
12,804
|
12,804
|
12,804
|
P/E ratio
|
39
x
|
18.6
x
|
31.7
x
|
15.5
x
|
12.7
x
|
9.8
x
|
Yield
|
0.48%
|
0.64%
|
1.77%
|
1.64%
|
1.59%
|
1.64%
|
Capitalization / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.66
x
|
0.61
x
|
0.49
x
|
EV / Revenue
|
1.67
x
|
0.81
x
|
0.96
x
|
0.66
x
|
0.61
x
|
0.49
x
|
EV / EBITDA
|
-
|
15.1
x
|
18.1
x
|
9.33
x
|
7.69
x
|
6.27
x
|
EV / FCF
|
-209
x
|
-10.6
x
|
11.6
x
|
55.9
x
|
-11.7
x
|
-
|
FCF Yield
|
-0.48%
|
-9.47%
|
8.6%
|
1.79%
|
-8.57%
|
-
|
Price to Book
|
6.96
x
|
2.85
x
|
1.94
x
|
1.4
x
|
1.27
x
|
1.16
x
|
Nbr of stocks (in thousands)
|
352,201
|
420,771
|
420,771
|
420,771
|
-
|
-
|
Reference price
2 |
73.82
|
55.49
|
39.64
|
30.43
|
30.43
|
30.43
|
Announcement Date
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
15,566
|
28,751
|
17,311
|
19,309
|
21,116
|
26,331
|
EBITDA
1 |
-
|
-
|
1,542
|
922.5
|
1,373
|
1,665
|
2,042
|
EBIT
1 |
-
|
617.5
|
1,240
|
560.4
|
882.2
|
1,089
|
1,402
|
Operating Margin
|
-
|
3.97%
|
4.31%
|
3.24%
|
4.57%
|
5.16%
|
5.33%
|
Earnings before Tax (EBT)
1 |
-
|
612.9
|
1,241
|
558.6
|
882.5
|
1,088
|
1,402
|
Net income
1 |
250.5
|
555.3
|
1,121
|
527.5
|
826.1
|
1,007
|
1,307
|
Net margin
|
-
|
3.57%
|
3.9%
|
3.05%
|
4.28%
|
4.77%
|
4.96%
|
EPS
2 |
0.9714
|
1.893
|
2.986
|
1.250
|
1.965
|
2.390
|
3.107
|
Free Cash Flow
1 |
-
|
-124.2
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
FCF margin
|
-
|
-0.8%
|
-7.69%
|
8.29%
|
1.19%
|
-5.2%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
155.55%
|
16.68%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
272.05%
|
27.72%
|
-
|
-
|
Dividend per Share
2 |
-
|
0.3571
|
0.3571
|
0.7000
|
0.5000
|
0.4850
|
0.5000
|
Announcement Date
|
18/07/21
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-124
|
-2,212
|
1,435
|
229
|
-1,097
|
-
|
ROE (net income / shareholders' equity)
|
-
|
18.7%
|
20.9%
|
6.3%
|
9.01%
|
10.2%
|
12%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
3.65%
|
4.79%
|
5.94%
|
7.73%
|
Assets
1 |
-
|
-
|
-
|
14,432
|
17,246
|
16,953
|
16,904
|
Book Value Per Share
2 |
-
|
10.60
|
19.50
|
20.40
|
21.80
|
24.00
|
26.30
|
Cash Flow per Share
2 |
-
|
-
|
-3.710
|
6.130
|
2.760
|
3.390
|
3.070
|
Capex
1 |
-
|
556
|
651
|
1,145
|
1,254
|
1,274
|
397
|
Capex / Sales
|
-
|
3.57%
|
2.26%
|
6.62%
|
6.49%
|
6.03%
|
1.51%
|
Announcement Date
|
18/07/21
|
25/01/22
|
19/01/23
|
17/01/24
|
-
|
-
|
-
|
Last Close Price
30.43
CNY Average target price
38.47
CNY Spread / Average Target +26.42% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.23% | 1.76B | | +20.09% | 68.02B | | -5.30% | 46.34B | | +22.19% | 43.77B | | +36.70% | 28.93B | | +11.89% | 19.86B | | +14.26% | 17.23B | | -25.77% | 14.95B | | -14.93% | 14.44B | | -31.27% | 11.82B |
Other Specialty Chemicals
|